Segment, Customer and Geographical Reporting

12 Months Ended

Sep. 30, 2012

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

 

Note 17 – Segment, Customer and Geographical Reporting

Results of Operations for the Fiscal Year Ended September 30,

2012

	Contract Research			Optics			Instruments			Biomedical			Total
Revenue		24,270,675			17,456,436			6,054,752			105,287			47,887,150
Gross Profit		8,859,780			7,125,962			3,436,542			83,459			19,505,743
SG&A		9,523,642			5,548,421			4,915,723			939,149			20,926,935
Impairment of goodwill		-			-			2,284,499			-			2,284,499
Operating Income (Loss)		(663,862	)		1,577,541			(3,763,680	)		(855,690	)		(3,705,691	)
GM %		36.5	%		40.8	%		56.8	%		79.3	%		40.7	%
Depreciation and Amortization		237,623			796,847			575,246			60,003			1,669,719
Capital expenditures		348,314			462,445			207,454			-			1,018,213
Intangibles, Net		366,853			960,821			5,135,634			239,997			6,703,305
Goodwill		4,938,625			1,300,463			4,015,072			-			10,254,160
Total Assets		12,870,151			11,588,145			12,537,403			469,729			37,465,428

Results of Operations for the Fiscal Year Ended September 30,

2011

	Contract Research			Optics			Instruments			Biomedical			Total
Revenue		24,874,088			15,839,205			6,238,373			-			46,951,666
Gross Profit		10,339,990			6,391,291			3,018,950			-			19,750,231
SG&A Costs		9,149,838			5,178,590			2,639,944			495,201			17,463,573
Operating Income (Loss)		1,190,152			1,212,700			379,007			(495,201	)		2,286,658
GM %		41.6	%		40.4	%		48.4	%		0.0	%		42.1	%
Depreciation and Amortization		147,687			581,464			503,922			-			1,233,073
Capital expenditures		284,098			915,978			343,186			-			1,543,262
Intangibles, Net		456,367			1,096,773			5,613,366			300,000			7,466,506
Goodwill		4,938,625			1,283,775			6,299,571			-			12,521,971
Total Assets		10,447,842			14,683,407			15,363,526			371,808			40,866,583

Customer Financial Information

For the years ended September 30, 2012 and 2011, the top three customers for the Contract Research segment were each various agencies of the U.S. Government. For the years ended September 30, 2012 and 2011, these customers made up 69.6% and 78.1%, respectively, of Contract Research revenue.

For the Optics segment, there was no customer whose revenue represented more than 10% of the total segment revenues for the years ended September 30, 2012 and 2011.

For the Instruments segment, there was one customer whose revenue represented 18.5% and 18.0, respectively of the Instruments segment revenue in the years ended September 30, 2012 and 2011.

For the Biomedical segment, there was one customer whose revenue represented 92.1% of the revenue for the year ended September 30, 2012. The Biomedical segment had no revenue or customers in the year ended September 30, 2011.

Geographic Financial Information

Revenues by geographic location in total and as a percentage of total revenue, for the years ended September 30, 2012 and 2011 are as follows:

	2012					2011
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	39,520,178		82.6	%	$	38,739,330		82.5	%
Europe		4,274,119		8.9	%		5,003,441		10.7	%
Other		4,092,853		8.5	%		3,208,895		6.8	%
	$	47,887,150		100.0	%	$	46,951,666		100.0	%